| Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies P Lesueur, F Chevalier, JB Austry, W Waissi, H Burckel, G Noel, ... Oncotarget 8 (40), 69105, 2017 | 117 | 2017 |
| Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol P Lesueur, J Lequesne, JM Grellard, A Dugué, E Coquan, PE Brachet, ... BMC cancer 19, 1-11, 2019 | 109 | 2019 |
| Radiosensitization effect of talazoparib, a parp inhibitor, on glioblastoma stem cells exposed to low and high linear energy transfer radiation P Lesueur, F Chevalier, EA El-Habr, MP Junier, H Chneiweiss, L Castera, ... Scientific Reports 8 (1), 3664, 2018 | 85 | 2018 |
| Hypoxia imaging and adaptive radiotherapy: a state-of-the-art approach in the management of glioma M Gérard, A Corroyer-Dulmont, P Lesueur, S Collet, M Chérel, ... Frontiers in medicine 6, 117, 2019 | 67 | 2019 |
| Proton therapy for treatment of intracranial benign tumors in adults: A systematic review P Lesueur, V Calugaru, C Nauraye, D Stefan, K Cao, E Emery, Y Reznik, ... Cancer treatment reviews 72, 56-64, 2019 | 59 | 2019 |
| Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer) P Lesueur, J Lequesne, V Barraux, W Kao, J Geffrelot, JM Grellard, ... Radiation Oncology 13, 1-10, 2018 | 42 | 2018 |
| Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC P Lesueur, A Escande, J Thariat, E Vauléon, I Monnet, A Cortot, ... Cancer medicine 7 (11), 5505-5513, 2018 | 38 | 2018 |
| Hadrontherapy interactions in molecular and cellular biology J Thariat, S Valable, C Laurent, S Haghdoost, EA Pérès, M Bernaudin, ... International journal of molecular sciences 21 (1), 133, 2019 | 23 | 2019 |
| Adenoid cystic carcinoma of the lacrimal gland: high dose adjuvant proton therapy to improve patients outcomes P Lesueur, E Rapeaud, L De Marzi, F Goudjil, C Levy, O Galatoire, ... Frontiers in Oncology 10, 135, 2020 | 21 | 2020 |
| Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world … M Sassier, AE Dugué, B Clarisse, P Lesueur, V Avrillon, ... Lung Cancer 89 (2), 161-166, 2015 | 20 | 2015 |
| High LET Radiation Overcomes In Vitro Resistance to X-Rays of Chondrosarcoma Cell Lines F Chevalier, DH Hamdi, C Lepleux, M Temelie, A Nicol, JB Austry, ... Technology in cancer research & treatment 18, 1533033819871309, 2019 | 12 | 2019 |
| Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study P Lesueur, G Damaj, K Hoang-Xuan, V Roland, A Schmitt, O Chinot, ... Blood Advances 6 (16), 4807-4815, 2022 | 10 | 2022 |
| Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review P Lesueur, I Martel-Laffay, A Escande, M Kissel, C Locher, R Gervais, ... Expert Review of Anticancer Therapy 18 (11), 1159-1165, 2018 | 10 | 2018 |
| Apports de la protonthérapie à la radiothérapie d’aujourd’hui, pourquoi, comment? J Thariat, JL Habrand, P Lesueur, A Chaikh, E Kammerer, D Lecomte, ... Bulletin du Cancer 105 (3), 315-326, 2018 | 10 | 2018 |
| Chondrosarcoma resistance to radiation therapy: Origins and potential therapeutic solutions A Gilbert, M Tudor, J Montanari, K Commenchail, DI Savu, P Lesueur, ... Cancers 15 (7), 1962, 2023 | 9 | 2023 |
| Hypofractionated stereotactic radiotherapy for challenging brain metastases using 36 Gy in six fractions DD Lecomte, J Lequesne, J Geffrelot, P Lesueur, V Barraux, C Loiseau, ... Cancer/Radiothérapie 23 (8), 860-866, 2019 | 9 | 2019 |
| Review of the mechanisms involved in the abscopal effect and future directions with a focus on thymic carcinoma P Lesueur, F Chevalier, D Stefan, JL Habrand, D Lerouge, R Gervais Tumori Journal 103 (3), 217-222, 2017 | 9 | 2017 |
| Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies. Oncotarget. 2017; 8: 69105–24 P Lesueur, F Chevalier, JB Austry, W Waissi, H Burckel, G Noel | 7 | 2019 |
| Vemurafenib and concomitant stereotactic radiation for the treatment of melanoma with spinal metastases: a case report D Stefan, H Popotte, AR Stefan, A Tesniere, A Tomaszewski, P Lesueur, ... Reports of Practical Oncology and Radiotherapy 21 (1), 76-80, 2016 | 6 | 2016 |
| Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial P Lesueur, W Kao, A Leconte, J Geffrelot, J Lequesne, J Lacroix, ... BMC cancer 20, 1-9, 2020 | 5 | 2020 |
